Total assets · 2011–2025
Iovance Biotherapeutics total assets
$913M+0.3% · FY2025
Iovance Biotherapeutics (IOVA) reported $913M in total assets for fiscal 2025, +0.3% year on year.
| Fiscal year | Total assets | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $913M | +0.3% | Open → |
| FY20242024-12-31 | $910M | +16.7% | Open → |
| FY20232023-12-31 | $780M | +17.5% | Open → |
| FY20222022-12-31 | $664M | −14.6% | Open → |
| FY20212021-12-31 | $777M | +1.2% | Open → |
| FY20202020-12-31 | $768M | +123.0% | Open → |
| FY20192019-12-31 | $345M | −28.3% | Open → |
| FY20182018-12-31 | $481M | +209.5% | Open → |
| FY20172017-12-31 | $155M | −9.6% | Open → |
| FY20162016-12-31 | $172M | +62.7% | Open → |
| FY20152015-12-31 | $106M | +127.2% | Open → |
| FY20142014-12-31 | $46.5M | +134.0% | Open → |
| FY20132013-12-31 | $19.9M | +67,467.6% | Open → |
| FY20122012-12-31 | $29,413 | −94.8% | Open → |
| FY20112011-12-31 | $568,430 | — | Open → |
Total assets — Total assets is everything the company owns at the balance-sheet date. Banks and insurers dominate this measure because customer deposits and policy reserves sit on their balance sheets.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +69.4%
Total assets at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Iovance Biotherapeutics total assets |url=https://companiesranked.com/en/company/iovance-biotherapeutics/total-assets |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Iovance Biotherapeutics total assets. CompaniesRanked. https://companiesranked.com/en/company/iovance-biotherapeutics/total-assetsBibTeX
@misc{companiesranked-en-company-iovance-biotherapeutics-total-assets-2026,
author = {{CompaniesRanked}},
title = {{Iovance Biotherapeutics total assets}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/iovance-biotherapeutics/total-assets}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001104659-26-091716 · August 6, 2026
{{cite web |title=Iovance Biotherapeutics total assets — 10-Q (0001104659-26-091716) |url=https://www.sec.gov/Archives/edgar/data/1425205/000110465926091716/iova-20260630x10q.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-06}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.